Skip to main content
OpenTrials
Completed

NCT Number: NCT04449497

The 2020 Quality of Death and Dying Index

Lien Centre for Palliative Care has been commissioned by Lien Foundation to produce the 2020 rankings of the Quality of End of Life Care across countries. This index will focus on patients with life limiting illnesses and their families and aims to produce an index and rankings that take into account the preferences of patients, their caregivers and providers in terms of what is truly important at end of life. The aim of this research is to investigate best practices in palliative care policy and implementation as they relate to end-of-life care for individuals with life-limiting or life-threatening conditions. This task will be completed through a systematic review of peer reviewed and grey literature, supplemented with qualitative interviews to identify the list of the candidate indicators to be used in the index. A final instrument when completed by country experts will allow for ranking countries in their ability to deliver high quality end of life care.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

21 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Duke-NUS Medical School

Singapore, 169857

About this study

Palliative care has gained considerable attention at the global, regional and national levels and there has been follow-up on actions outlined in the 2014 World Health Assembly (WHA) Resolution on palliative care. The WHA Resolution called countries to action to integrate palliative care into their national health strategies and as part of universal health coverage (UHC) efforts. Further, important contributions have been made to the literature on palliative care overall and at the end of life, such as by the Lancet Commission on Global Access to Palliative Care and Pain Relief as well as on quality healthcare.

Through this research, the Quality of Death and Dying Index will be published and it seeks to facilitate monitoring of country-level progress based on domains/sub-domains and indicators used to define quality of death and dying in the discourse on end-of-life care, and within the context of the contrasting realities occurring worldwide. Examining the various trajectories that countries have followed and the experiences of end-of-life care design and delivery by countries from different income groups and based on the viewpoint of diverse stakeholders will provide critical information for metrics development, namely the 2020 Quality of Death and Dying Index

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

for experts:

  • Technical expert with 10 or more years of experience in the field of palliative care and/or end-of-life care at the global, regional or national levels.
  • Current or former policy maker, at the state or national level and having actively engaged in development of policies and strategies on palliative care and/or end-of-life care.
  • Physicians, nurses and/or community health workers who have training to and have actively delivered end-of-life care.

For caregivers

  • In the past two years, lost a family member or close friend after a brief or extended period of illness or injury.
  • Involved in discussions with health care providers concerning the patient's choice of treatments
  • Involved in helping the patient receive medical care, such as accompanying the patient to doctor's visits.
  • Involved in looking after the patient's day to day well-being.

Exclusion criteria

  • For patients 1. Individuals with physical, emotional or cognitive limitations which may prevent them from participating or comprehending the questions.

For all participants

  • Inability to understand English.
  • Minor and not below the age of 21 years.

Treatment and study plan

Primary outcomes

  1. Ranking of countries

    Time frame: 2 years

    Ranking of countries in their ability to deliver high quality end of life care.

Sponsors and collaborators

Lead sponsor

Duke-NUS Graduate Medical School

Other

Registry information

Acronym: QODDI

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Jun 26, 2020
Registry last updated
Feb 21, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.